StonvexLoading…
StonvexStonvexStonvexCore line items from NCSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $45.64M | $183.63M | $133.00M | $86.46M |
Operating Income | $848.00K | $10.54M | $5.32M | $2.26M |
Net Income | $-371.00K | $23.75M | $8.79M | $4.98M |
EPS (Diluted) | $-0.14 | $8.65 | $3.22 | $1.84 |
Total Assets | $174.58M | $181.20M | $162.02M | $157.98M |
Total Liabilities | $30.78M | $38.10M | $34.91M | $34.00M |
Cash & Equivalents | $34.46M | $36.73M | $25.30M | $25.37M |
Free Cash Flow OCF − CapEx | $689.00K | $20.97M | $8.07M | $1.13M |
Shares Outstanding | 2.62M | 2.55M | 2.54M | 2.54M |